Medpace ( MEDP ) Is Up 5.41% in One Week: What You Should Know
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's HSA growth, AI-driven efficiencies, and strong Q1 results fuel optimism despite data security concerns.
RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti posts a narrower adjusted Q2 loss and unveils its largest quantum computer, but revenue declines 41.6% year over year.
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins.
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.
CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls
Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up
Exact Sciences tops on Q2 earnings and revenue estimates and raises the 2025 outlook, but shares slide 8% after results.
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
PODD posts strong Q2 earnings and revenues and lifts its 2025 outlook, marking a decade of 20%+ constant-currency growth.
EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up
National Vision tops on Q2 earnings and revenues, boosts 2025 guidance after strong sales and margin expansion.
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up
Veracyte Q2 earnings and revenues beat estimates, fueled by Decipher and Afirma growth, sending shares up over 15%.
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract
BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.
TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up
Tandem Diabetes posts record Q2 sales and higher margins, but earnings miss sends shares tumbling 20%.
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
PACB stock jumps after Q2 results beat estimates, with narrow losses, rising margins, and strong global demand.
Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve
SOLV jumps 5% as Q2 earnings and revenues beat estimates. EPS outlook raised on broad-based segment growth.
TEM's Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
Tempus AI posts a narrower Q2 loss and an 89.6% revenue surge, driven by genomics growth and new oncology-focused product launches.
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up
DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y
Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand
QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
Cencora posts strong Q3 results with earnings and revenues surpassing estimates. raises FY25 EPS guidance on robust U.S. segment growth.
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.
IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics stock jumps 10.5% as Q2 EPS beats by 91.7%, revenue rises 37.7%, and operating margin expands 1230 basis points.
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
Glaukos' second-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CNMD reports solid second-quarter results, driven by improving sales across both segments.
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth.
Healthcare Analytical Testing Services Market is expected to generate a revenue of USD 9.56 Billion by 2031, Globally, at 11.20% CAGR: Verified Market Research®
Lewes, Delaware, July 31, 2025 ( GLOBE NEWSWIRE ) -- The Global Healthcare Analytical Testing Services Market Size is projected to grow at a CAGR of 11.20% from 2024 to 2031, according to a new report published by Verified Market Research®.
Should You Buy Medpace ( MEDP ) After Golden Cross?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down
HOLX posts better-than-expected Q3 results, but margin contraction and regional headwinds pressure investor sentiment.
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
Insider Decision: August J Troendle Offloads $21.90M Worth Of Medpace Hldgs Stock - Medpace Hldgs ( NASDAQ:MEDP )
August J Troendle, CEO at Medpace Hldgs MEDP, reported an insider sell on July 29, according to a new SEC filing. What Happened: Troendle's decision to sell 48,487 shares of Medpace Hldgs was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.
Ecolab Stock Down in Pre-Market Post Q2 Earnings Miss, Margins Expand
ECL stock dips in pre-market despite second-quarter 2025 earnings growth and margin expansion, as EPS misses estimates by a penny.
At Medpace Hldgs, Jesse J Geiger Chooses To Exercise Options, Resulting In $13.59M
Disclosed in a recent SEC filing on July 28, Geiger, President at Medpace Hldgs MEDP, made a noteworthy transaction involving the exercise of company stock options. What Happened: Geiger, President at Medpace Hldgs, exercised stock options for 41,801 shares of MEDP stock.
Uber To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday - Amkor Tech ( NASDAQ:AMKR ) , AutoNation ( NYSE:AN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Stephens & Co. raised AutoNation, Inc. AN price target from $190 to $200.
What Makes Medpace ( MEDP ) a New Strong Buy Stock
Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for July 28th
CALX, MEDP and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2025.
New Strong Buy Stocks for July 28th
MEDP, CBFV, CALX, TREE and HAS have been added to the Zacks Rank #1 (Strong Buy) List on July 28, 2025.
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week ( July 21-July 25 ) : Are The Others In Your Portfolio? - Astera Labs ( NASDAQ:ALAB ) , Baker Hughes ( NASDAQ:BKR )
Medpace surged over 137% after crushing Q2 earnings estimates. Strong earnings and raised guidance drove sharp gains in pharma and tech names. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily. These ten large-cap stocks were top performers last week.
Medpace Hldgs's Options: A Look at What the Big Money is Thinking - Medpace Hldgs ( NASDAQ:MEDP )
Deep-pocketed investors have adopted a bearish approach towards Medpace Hldgs MEDP, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Engaging In Options Activity, Cornelius P. McCarthy III Exercises Options Valued At $740K In Medpace Hldgs - Medpace Hldgs ( NASDAQ:MEDP )
Highlighted on July 24, it was unveiled in an SEC filing that III, Director at Medpace Hldgs MEDP, executed a significant transaction involving the exercise of company stock options. What Happened: Disclosed in a Form 4 filing on Thursday with the U.S.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Witnessing An Insider Decision, Cornelius P. McCarthy III Exercises Options Valued At $1.85M At Medpace Hldgs - Medpace Hldgs ( NASDAQ:MEDP )
In a new SEC filing on July 22, it was revealed that III, Board Member at Medpace Hldgs MEDP, executed a significant exercise of company stock options. What Happened: A notable Form 4 filing on Tuesday with the U.S.
This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Centene ( NYSE:CNC ) , Boot Barn Holdings ( NYSE:BOOT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Seaport Global analyst Tom Curran downgraded the rating for Fluence Energy, Inc.
